methoxyhydroxyphenylglycol has been researched along with fluoxetine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 9 (75.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brickman, A; Goodnick, PJ; Klimas, NG; Sandoval, R | 1 |
| Bertilsson, L; Brodin, E; Mårtensson, B; Nyberg, S; Toresson, G | 1 |
| Sugrue, MF | 1 |
| Anderson, GM; Cohen, DJ; Hall, LM | 1 |
| Cooper, T; Coplan, JD; Gorman, JM; Martinez, J; Papp, L; Pine, D; Rosenblum, LA | 1 |
| Bardgett, ME; Csernansky, JG; Sheline, Y | 1 |
| Hwang, CC; Ko, HC; Lu, RB; Shiah, IS | 1 |
| Cooper, T; Coplan, JD; Gorman, JM; Klein, DF; Martinez, J; Papp, LA; Pine, D; Rosenblum, LA | 1 |
| Fuller, RW; Perry, KW | 1 |
| Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A | 1 |
| Clarke, AS; Ebert, MH; Kraemer, GW; McKinney, WT; Schmidt, DE | 1 |
| Lima, L; Manzano, E; Mata, S; Ortiz, T; Urbina, M | 1 |
3 trial(s) available for methoxyhydroxyphenylglycol and fluoxetine
| Article | Year |
|---|---|
Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Selective Serotonin Reuptake Inhibitors | 1997 |
Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Depressive Disorder; Female; Fluoxetine; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Personality Inventory; Prognosis; Serotonin; Treatment Outcome | 1997 |
Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome".
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Blood Platelets; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Reference Values; Selective Serotonin Reuptake Inhibitors; Syndrome | 1998 |
9 other study(ies) available for methoxyhydroxyphenylglycol and fluoxetine
| Article | Year |
|---|---|
Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome.
Topics: Adult; Bupropion; Depressive Disorder; Fatigue Syndrome, Chronic; Female; Fluoxetine; Follow-Up Studies; Homovanillic Acid; Humans; Immunity, Cellular; Male; Methoxyhydroxyphenylglycol; Middle Aged; Personality Inventory | 1992 |
Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
Topics: Adult; Aged; Depressive Disorder; Female; Fluoxetine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Peptide Fragments; Substance P | 1989 |
Effects of acutely and chronically administered antidepressants on the clonidine-induced decrease in rat brain 3-methoxy-4-hydroxyphenylethylene-glycol sulphate content.
Topics: Animals; Antidepressive Agents; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Clonidine; Desipramine; Fluoxetine; Glycols; Iprindole; Male; Methoxyhydroxyphenylglycol; Mianserin; Rats | 1981 |
Acute and chronic effects of fluoxetine and haloperidol on mouse brain serotonin and norepinephrine turnover.
Topics: Animals; Brain; Dopamine; Fluoxetine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Rats; Serotonin; Species Specificity | 1995 |
Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients.
Topics: Adrenal Cortex; Adult; Clonidine; Female; Fluoxetine; Humans; Hypothalamo-Hypophyseal System; Male; Methoxyhydroxyphenylglycol; Panic Disorder | 1995 |
Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
Topics: Adult; Clonidine; Female; Fluoxetine; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Panic Disorder; Receptors, Adrenergic; Treatment Outcome | 1997 |
Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Desipramine; Dialysis Solutions; Dopamine; Extracellular Space; Fluoxetine; Hydroxyindoleacetic Acid; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin | 1997 |
Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animal Husbandry; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety, Separation; Behavior, Animal; Binding, Competitive; Biogenic Amines; Desipramine; Fluoxetine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Methoxyhydroxyphenylglycol; Random Allocation; Social Environment; Time Factors | 1999 |
Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression.
Topics: Adult; Blood Platelets; Cell Membrane; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Lymphocytes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Serotonin | 2005 |